Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Filters
Results by year
Table representation of search results timeline featuring number of search results per year.
Year | Number of Results |
---|---|
2001 | 1 |
2004 | 1 |
2024 | 0 |
Search Results
2 results
Results by year
Filters applied: . Clear all
Page 1
Treatment of advanced human immunodeficiency virus type 1 disease with the viral entry inhibitor PRO 542.
Antimicrob Agents Chemother. 2004 Feb;48(2):423-9. doi: 10.1128/AAC.48.2.423-429.2004.
Antimicrob Agents Chemother. 2004.
PMID: 14742190
Free PMC article.
Clinical Trial.
Structural flexibility and functional valence of CD4-IgG2 (PRO 542): potential for cross-linking human immunodeficiency virus type 1 envelope spikes.
Zhu P, Olson WC, Roux KH.
Zhu P, et al.
J Virol. 2001 Jul;75(14):6682-6. doi: 10.1128/JVI.75.14.6682-6686.2001.
J Virol. 2001.
PMID: 11413335
Free PMC article.
Item in Clipboard
Cite
Cite